Aspirin, Dipyridamole Drug Combination
Showing 1 - 25 of >10,000
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
COVID-19 Trial in India (Brequinar Sodium, Dipyridamole 75 MG, Placebo)
Terminated
- COVID-19
- Brequinar Sodium
- +2 more
-
Srikakulam, Andhra Pradesh, India
- +6 more
Jun 16, 2022
Systemic Lupus Erythematosus Trial in Oklahoma City (extended release dipyridamole 200mg/aspirin 25mg, 81mg aspirin)
Terminated
- Systemic Lupus Erythematosus
- extended release dipyridamole 200mg/aspirin 25mg
- 81mg aspirin
-
Oklahoma City, OklahomaOklahoma Medical Research Foundation
Nov 3, 2020
Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)
Recruiting
- Sarpogrelate
- +3 more
- Sarpogrelate Sustained Release/Aspirin
- Aspirin
-
Uijeongbu, Gyeonggi-do, Korea, Republic ofThe Catholic University of Korea Uijeongbu St. Mary's Hospital
Feb 6, 2023
Healthy Volunteer Trial in Leeds (Aspirin, rivaroxaban low dose, rivaroxaban high dose)
Recruiting
- Healthy Volunteer
- Aspirin
- +2 more
-
Leeds, West Yorkshire, United KingdomLabCorp CRU
Jan 24, 2023
Infertility, Female Trial in Las Vegas (Lovenox, Aspirin, Embryo transfer)
Not yet recruiting
- Infertility, Female
- Lovenox
- +2 more
-
Las Vegas, NevadaFertility center of Las Vegas
Nov 15, 2023
Aspirin in Combination With Trametinib and Dabrafenib
Not yet recruiting
- NSCLC
- +4 more
- Combind asprin with Trametinib and Dabrafenib
- (no location specified)
Aug 4, 2023
COVID, Corona Virus Infection, Covid-19 Trial in Ann Arbor (Dipyridamole 100 Milligram(mg), Placebo oral tablet)
Completed
- COVID
- +3 more
- Dipyridamole 100 Milligram(mg)
- Placebo oral tablet
-
Ann Arbor, MichiganUniversity of Michigan
Mar 18, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenoma Trial (Aspirin tablet, Metformin, Aspirin and Metformin)
Not yet recruiting
- Colorectal Cancer
- +2 more
- Aspirin tablet
- +2 more
- (no location specified)
May 17, 2022
Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)
Active, not recruiting
- Colo-rectal Cancer
- Metastatic Cancer
- Regorafenib
- +3 more
-
Besançon, France
- +2 more
Jan 24, 2023
Metastatic Colorectal Cancer Trial in France (other, procedure, drug)
Not yet recruiting
- Metastatic Colorectal Cancer
- quality of life questionnaires
- +6 more
-
Besançon, France
- +6 more
Jul 15, 2022
Coronary Artery Disease, Healthy Participants Trial in Edinburgh (Ticagrelor, BMS-986141, Aspirin)
Recruiting
- Coronary Artery Disease
- Healthy Participants
- Ticagrelor
- +2 more
-
Edinburgh, United KingdomLocal Institution - 0001
May 3, 2022
NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)
Not yet recruiting
- Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
- (no location specified)
Aug 27, 2023
Venous Thromboembolism Trial in Halifax (Rivaroxaban 10 MG and acetylsalicylic acid 81 mg, acetylsalicylic acid 81 mg)
Recruiting
- Venous Thromboembolism
- Rivaroxaban 10 MG and acetylsalicylic acid 81 mg
- acetylsalicylic acid 81 mg
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II HSC
Jul 27, 2022
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Pediatric ALL Trial in Worldwide (Methylprednisolone, Prednisolone)
Recruiting
- Paediatric Stroke
-
Randwick, New South Wales, Australia
- +26 more
Jan 13, 2023
Venous Thromboembolic Disease Trial in France (Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP))
Not yet recruiting
- Venous Thromboembolic Disease
- Full-dose anticoagulant therapy (AC)
- Antiplatelet therapy (AP)
-
Amiens, France
- +27 more
Jan 13, 2023
Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)
Not yet recruiting
- Acute Ischemic Stroke
- Thrombocytopenia
- aspirin, clopidogrel, cilostazol, and dipyridamole
- (no location specified)
Sep 21, 2023
Preeclampsia Postpartum Trial in New York (Aspirin, Placebo oral capsule)
Recruiting
- Preeclampsia Postpartum
- Aspirin tablet
- Placebo oral capsule
-
New York, New YorkColumbia University Irving Medical Center
Dec 23, 2022
Peripheral Arterial Disease Trial (Rivaroxaban and Aspirin)
Not yet recruiting
- Peripheral Arterial Disease
- Rivaroxaban and Aspirin
- (no location specified)
Jul 19, 2022
Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )
Completed
- Prevention & Control
- Rivaroxaban (Xarelto, BAY59-7939)
- +5 more
-
Birmingham, Alabama
- +564 more
Nov 3, 2022
Left Ventricular Assist Device Patients
Completed
- End-stage Heart Failure
- +2 more
- VerifyNow antiplatelet therapy response test
-
Vienna, AustriaMedical University of Vienna
Nov 28, 2023
Coronary Artery Disease Trial in Seoul (Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin)
Recruiting
- Coronary Artery Disease
- Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin
-
Seoul, Korea, Republic of
- +1 more
Nov 10, 2021